Kidney Genetic Diseases Program

About Rumi Scientific

Rumi Scientific, founded in 2015 and based in New York, is a private biotech company developing a predictive discovery platform for central nervous system (CNS) and renal diseases. Its core technology involves standardized, high-throughput 'neuroloid' and kidney organoid models that mimic human tissue development and disease, enabling quantitative screening of compounds and genetic perturbations. By integrating human biology with artificial intelligence, Rumi aims to de-risk drug discovery, identify novel targets, and build an internal therapeutic pipeline, positioning itself at the intersection of stem cell biology, physics, and data science.

Therapeutic Areas